Mikhail Melnikov

Prof. Dr. Mikhail Melnikov

Lomonosov Moscow State Univeristy, Chemistry Department
orcid

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2017 in Synthesis
Verified
Journal Article
Closed access
PDF file
EBEkaterina M. Budynina
Ekaterina M. Budynina
KIKonstantin L. Ivanov
Konstantin L. Ivanov
ISIvan D. Sorokin
Ivan D. Sorokin
MMMikhail Melnikov
Mikhail Melnikov
Ring opening of donor–acceptor cyclopropanes with various N-nucleophiles provides a simple approach to 1,3-functionalized compounds that are useful building blocks in organic synthesis, especially in assembling various N-heterocycles, including natural products. In this review, ring-opening reactions of donor–acceptor cyclopropanes with amines, amides, hydrazines, N-heterocycles, nitriles, and the azide ion are summarized.1 Introduction2 Ring Opening with Amines3 Ring Opening with Amines Accompanied by Secondary Processes Involving the N-Center3.1 Reactions of Cyclopropane-1,1-diesters with Primary and Secondary Amines3.1.1 Synthesis of γ-Lactams3.1.2 Synthesis of Pyrroloisoxazolidines and -pyrazolidines3.1.3 Synthesis of Piperidines3.1.4 Synthesis of Azetidine and Quinoline Derivatives3.2 Reactions of Ketocyclopropanes with Primary Amines: Synthesis of Pyrrole Derivatives3.3 Reactions of Сyclopropane-1,1-dicarbonitriles with Primary Amines: Synthesis of Pyrrole Derivatives4 Ring Opening with Tertiary Aliphatic Amines5 Ring Opening with Amides6 Ring Opening with Hydrazines7 Ring Opening with N-Heteroaromatic Compounds7.1 Ring Opening with Pyridines7.2 Ring Opening with Indoles7.3 Ring Opening with Di- and Triazoles7.4 Ring Opening with Pyrimidines8 Ring Opening with Nitriles (Ritter Reaction)9 Ring Opening with the Azide Ion10 Summary

8 January 2015 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
KIKonstantin L. Ivanov
Konstantin L. Ivanov
EVElena V. Villemson
Elena V. Villemson
EBEkaterina M. Budynina
Ekaterina M. Budynina
IOIvanova Olga
Ivanova Olga
Igor TrushkovIgor Trushkov
Igor Trushkov
MMMikhail Melnikov
Mikhail Melnikov

17 July 2020 in Magnetochemistry
Verified
Journal Article
Open access
PDF file
TSTatyana Shabatina
Tatyana Shabatina
OVO. I. Vernaya
O. I. Vernaya
VSVladimir P. Shabatin
Vladimir P. Shabatin
MMMikhail Melnikov
Mikhail Melnikov
The presented paper is a review article discussing existing synthesis methods and different applications of nanosized magnetic nanoparticles. It was shown that, in addition to the spectrum of properties typical for nanomaterials (primarily a large specific surface area and a high fraction of surface atoms), magnetic nanoparticles also possess superparamagnetic properties that contribute to their formation of an important class of biomedical functional nanomaterials. This primarily concerns iron oxides magnetite and maghemite, for which in vitro and in vivo studies have shown low toxicity and high biocompatibility in comparison with other magnetic nanomaterials. Due to their exceptional chemical, biological, and physical properties, they are widely used in various areas, such as magnetic hyperthermia, targeted drug delivery, tissue engineering, magnetic separation of biological objects (cells, bacteria, viruses, DNA, and proteins), and magnetic diagnostics (they are used as agents for MRS and immunoassay). In addition to discussing the main problems and prospects of using nanoparticles of magnetic iron oxides for advanced biomedical applications, information is also reflected on their structure, production methods, and properties.

26 September 2011 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
IOIvanova Olga
Ivanova Olga
EBEkaterina M. Budynina
Ekaterina M. Budynina
ACAlexey O. Chagarovskiy
Alexey O. Chagarovskiy
Igor TrushkovIgor Trushkov
Igor Trushkov
MMMikhail Melnikov
Mikhail Melnikov

7 December 2010 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
PDF file
ACAlex Chagarovskiy
Alex Chagarovskiy
IOIvanova Olga
Ivanova Olga
EREduard R. Rakhmankulov
Eduard R. Rakhmankulov
EBEkaterina M. Budynina
Ekaterina M. Budynina
Igor TrushkovIgor Trushkov
Igor Trushkov
MMMikhail Melnikov
Mikhail Melnikov

7 April 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TSTatyana Shabatina
Tatyana Shabatina
OVO. I. Vernaya
O. I. Vernaya
NSNikolai lvovich Shimanovskii
Nikolai lvovich Shimanovskii
MMMikhail Melnikov
Mikhail Melnikov
The development of antiviral treatment and anticancer theragnostic agents in recent decades has been associated with nanotechnologies, and primarily with inorganic nanoparticles (INPs) of metal and metal oxides. The large specific surface area and its high activity make it easy to functionalize INPs with various coatings (to increase their stability and reduce toxicity), specific agents (allowing retention of INPs in the affected organ or tissue), and drug molecules (for antitumor and antiviral therapy). The ability of magnetic nanoparticles (MNPs) of iron oxides and ferrites to enhance proton relaxation in specific tissues and serve as magnetic resonance imaging contrast agents is one of the most promising applications of nanomedicine. Activation of MNPs during hyperthermia by an external alternating magnetic field is a promising method for targeted cancer therapy. As therapeutic tools, INPs are promising carriers for targeted delivery of pharmaceuticals (either anticancer or antiviral) via magnetic drug targeting (in case of MNPs), passive or active (by attaching high affinity ligands) targeting. The plasmonic properties of Au nanoparticles (NPs) and their application for plasmonic photothermal and photodynamic therapies have been extensively explored recently in tumor treatment. The Ag NPs alone and in combination with antiviral medicines reveal new possibilities in antiviral therapy. The prospects and possibilities of INPs in relation to magnetic hyperthermia, plasmonic photothermal and photodynamic therapies, magnetic resonance imaging, targeted delivery in the framework of antitumor theragnostic and antiviral therapy are presented in this review.